Avalo Therapeutics

AVTX · NASDAQ

$12.36+$0.77 (+6.64%)TodayMarket closed ·
Prev close $11.59

Who owns AVTX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 55.7% of AVTX’s shares.

  • Deep Track Capital LP6.8%
  • Fidelity Management & Research Company LLC6.6%
  • BlackRock Institutional Trust Company, N.A.6.1%
  • Caligan Partners, LP6.0%
  • Next 6 largest institutions30.3%
  • All other shareholders44.3%
Top institutional holders of AVTX
HolderShares% of shares
Deep Track Capital LP3.61M6.82%
Fidelity Management & Research Company LLC3.48M6.57%
BlackRock Institutional Trust Company, N.A.3.21M6.07%
Caligan Partners, LP3.16M5.98%
TCG Crossover Management, LLC3.02M5.70%
Affinity Asset Advisors LLC2.90M5.48%
State Street Investment Management (US)2.89M5.46%
Farallon Capital Management, L.L.C.2.50M4.72%
Point72 Asset Management, L.P.2.39M4.51%
Avoro Capital Advisors LLC2.33M4.41%

Largest mutual fund holders

Top mutual fund holders of AVTX
HolderShares% of shares
State Street SPDR S&P Biotech ETF2.14M4.05%
Vanguard Total Stock Market Index Fund1.68M3.17%
Fidelity Stock Selector Small Cap Fund1.21M2.29%
iShares Russell 2000 ETF1.09M2.06%
Fidelity Series Small Cap Opportunities Fund715.70K1.35%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $7.57M (34 trades) of AVTX on the open market, with no buys.

Latest AVTX insider transactions
InsiderTypeSharesValue
Philip Ron MAward1.11K$13.63K
Jain RitaAward1.32K$16.25K
Lind Kevin RobertAward1.35K$16.62K
Sullivan Christopher RyanOption exercise12.39K—
Sullivan Christopher RyanSale12.39K$202.44K
Sullivan Christopher RyanOption exercise12.39K$122.45K
Sullivan Christopher RyanOption exercise10.19K—
Sullivan Christopher RyanSale10.19K$179.46K
Sullivan Christopher RyanOption exercise10.19K$81.89K
Doyle MittieOption exercise679—

Short interest

Settled Sep 30, 2026

Shares short
11.41M
Days to cover
8.80
% of shares outstanding
21.56%
Average daily volume
1.30M
Change since last report
−11.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.